Robert Albin
Pulmonary Disease · Atlanta, GANPI 1619057668
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,159 and has fallen 97.3% since, to $32 in 2024. That places this record below the midpoint for pulmonary disease clinicians in GA, where the typical reported total is $3,789.
Across 129 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$559
- AstraZeneca$386
- Harmony Biosciences LLC$325
- Boehringer Ingelheim$324
- Monaghan Medical Corporation$150
- Grifols USA, LLC$126
- plus $723 from 15 others
What the payments were for
- Food & beverage$2,593100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 33 | $559 |
| AstraZeneca | 21 | $386 |
| Harmony Biosciences LLC | 13 | $325 |
| Boehringer Ingelheim | 16 | $324 |
| Monaghan Medical Corporation | 1 | $150 |
| Grifols USA, LLC | 8 | $126 |
| Jazz Pharmaceuticals Inc. | 6 | $124 |
| Mylan Specialty L.p. | 7 | $113 |
| Fisher & Paykel Healthcare Inc | 1 | $88 |
| Sunovion Pharmaceuticals Inc. | 5 | $60 |
| Advanced Respiratory, Inc | 2 | $51 |
| Insmed, Inc. | 2 | $48 |
| Novartis | 3 | $46 |
| Boston Scientific | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Circassia Inc. | 2 | $28 |
| Mallinckrodt Enterprises LLC | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Electromed, Inc. | 2 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aerobika$150
How this compares
$2,593 in reported general payments places this provider in the 40th percentile of 365 pulmonary disease providers in Georgia.
Other pulmonary disease in Atlanta
- Colin SwensonAtlanta$255K
- Eric FlenaughAtlanta$93K
- Gregory MartinAtlanta$88K
- Victor TsengAtlanta$55K
- Ralitza MartinAtlanta$48K
- Venkatesh LakshminarayananAtlanta$33K
- Sisir AkkineniAtlanta$21K
- Gerald StatonAtlanta$21K
- Mirza AliAtlanta$16K
- Srihari VeeraraghavanAtlanta$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.